Care in the field: adult anaphylaxis for paramedics
pdf

Keywords

Anaphylaxis
Paramedic

How to Cite

1.
Wilkinson-Stokes M, Rowland D, Spencer M, Maria S, Colbeck M. Care in the field: adult anaphylaxis for paramedics. Australasian Journal of Paramedicine [Internet]. 2021Sep.15 [cited 2021Dec.4];18. Available from: https://ajp.paramedics.org/index.php/ajp/article/view/916

Abstract

This paper presents an overview of the definition, clinical features, epidemiology, classification, pathophysiology, evaluation and risk assessment and treatment pharmacodynamics of anaphylaxis from the perspective of Australasian paramedic practice.

https://doi.org/10.33151/ajp.18.916
pdf

References

Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol 2017;140:335-48. Available at: https://linkinghub.elsevier.com/retrieve/pii/S0091674917310205

Simons FER, Ardusso LRF, Bilò MB, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014;7:9. Available at: https://linkinghub.elsevier.com/retrieve/pii/S1939455119302406

Kemp SF. Pathophysiology of anaphylaxis. In: Kelso JM, Feldweg AM, editors. UpToDate. Waltham, MA: UpToDate; 2020.

Australasian Society of Clinical Immunology and Allergy. Anaphylaxis 2019. Available at: www.allergy.org.au/patients/about-allergy/anaphylaxis

Jimenez-Rodriguez T, Garcia-Neuer M, Alenazy LA, Castells M. Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers. J Asthma Allergy 2018;11:121-42. Available at: www.dovepress.com/anaphylaxis-in-the-21st-century-phenotypes-endotypes-and-biomarkers-peer-reviewed-article-JAA

Campbell RL, Kelso JM. Anaphylaxis: acute diagnosis. In: Walls RM, Feldweg AM, editors. UpToDate. Waltham, MA: UpToDate; 2020.

Australasian Society of Clinical Immunology and Allergy. Allergy and Immune Diseases in Australia (AIDA) Report 2013. Balgowah, Australia; 2013.

House of Representatives Standing Committee on Health Aged Care and, Sport. Walking the allergy tightrope: addressing the rise of allergies and anaphylaxis in Australia. 2020. Available at: www.allergy.org.au/images/docs/Walkingtheallergytightrope.pdf

Turner PJ, Jerschow E, Umasunthar T, et al. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract 2017;5:1169-78. Available at: https://linkinghub.elsevier.com/retrieve/pii/S2213219817305159

Xu YS, Kastner M, Harada L, et al. Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011. Allergy Asthma Clin Immunol 2014;10:38. Available at: https://aacijournal.biomedcentral.com/articles/10.1186/1710-1492-10-38

Tanno LK, Bierrenbach AL, Simons FER, et al. Critical view of anaphylaxis epidemiology: open questions and new perspectives. ibid. 2018;14:12. Available at: https://aacijournal.biomedcentral.com/articles/10.1186/s13223-018-0234-0

Turner PJ, Worm M, Ansotegui IJ, et al. Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organ J 2019;12:100066. Available at: https://linkinghub.elsevier.com/retrieve/pii/S1939455119312207

LoVerde D, Iweala OI, Eginli A, Krishnaswamy G. Anaphylaxis. Chest 2018;153:528-43. Available at: https://linkinghub.elsevier.com/retrieve/pii/S0012369217313326

Montañez MI, Mayorga C, Bogas G, et al. Epidemiology, mechanisms, and diagnosis of drug-induced anaphylaxis. Front Immunol 2017;8. Available at: http://journal.frontiersin.org/article/10.3389/fimmu.2017.00614/full

Fenny N, Grammer LC. Idiopathic anaphylaxis. Immunol Allergy Clin North Am 2015;35:349-62. Available at: https://linkinghub.elsevier.com/retrieve/pii/S0889856115000053

Denholm L, Gallagher G. Physiology and pharmacology of nausea and vomiting. Anaesth Intensive Care Med 2018;19:513-6. Available at: https://linkinghub.elsevier.com/retrieve/pii/S1472029918301541

Bot I, Shi G-P, Kovanen PT. Mast cells as effectors in atherosclerosis. Arterioscler Thromb Vasc Biol 2015;3:265-71. Available at: www.ahajournals.org/doi/10.1161/ATVBAHA.114.303570

Lagraauw HM, Wezel A, van der Velden D, Kuiper J, Bot I. Stress-induced mast cell activation contributes to atherosclerotic plaque destabilization. Sci Rep 2019;9:2134. Available at: www.nature.com/articles/s41598-019-38679-4

Mali S, Jambure R. Anaphylaxis management: current concepts. Anesth Essays Res 2012;6:115. Available at: www.aeronline.org/text.asp?2012/6/2/115/108284

Marone G, Genovese A, Varricchi G, Granata F. Human heart as a shock organ in anaphylaxis. Allergo J Int 2014;23:60-6. Available at: http://link.springer.com/10.1007/s40629-014-0007-3

Campbell RL, Kelso JM. Anaphylaxis: emergency treatment. In: Walls RM, Randolph AG, Feldweg AM, editors. UpToDate. Waltham, MA: UpToDate; 2020.

Ring J, Beyer K, Biedermann T, et al. Guideline for acute therapy and management of anaphylaxis. Allergo J Int 2014;23:96-112. Available at: http://link.springer.com/10.1007/s40629-014-0009-1

Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin Exp Allergy 2011;41:923-38. Available at: http://doi.wiley.com/10.1111/j.1365-2222.2011.03779.x

Bock SA. Fatal anaphylaxis. In: Kelso J, Feldweg A, editors. UpToDate. Waltham, MA: UpToDate; 2020.

Arts L, Lim EHT, van de Ven PM, Heunks L, Tuinman PR. The diagnostic accuracy of lung auscultation in adult patients with acute pulmonary pathologies: a meta-analysis. Sci Rep 2020;10:1-11.

Tupper J. Anaphylaxis: a review and update. Can Fam Physician 2010;56:1009-11.

Lieberman PL. Biphasic and protracted anaphylaxis. In: Kelso JM, Feldweg AM, editors. UpToDate. Waltham, MA: UpToDate; 2020.

Simons FER, Ardusso LRF, Bilò MB, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011;4:13-37. Available at: https://linkinghub.elsevier.com/retrieve/pii/S1939455119304132

Maurer M, Magerl M. Hereditary angioedema: an update on available therapeutic options. JDDG J der Dtsch Dermatologischen Gesellschaft 2010;8:663-72. Available at: http://doi.wiley.com/10.1111/j.1610-0387.2010.07450.x

Craig T, Pürsün EA, Bork K, et al. WAO guideline for the management of hereditary angioedema. World Allergy Organ J 2012;5:182-99. Available at: www.waojournal.org/content/5/12/182

Ring J, Klimek L, Worm M. Adrenaline in the acute treatment of anaphylaxis. Dtsch Aerzteblatt Online 2018; Available at: www.aerzteblatt.de/10.3238/arztebl.2018.0528

Kay LJ, Peachell PT. Mast cell beta2-adrenoceptors. In: Mast Cells in Allergic Diseases. Basel: KARGER; 2005. p. 145-53. Available at: www.karger.com/Article/FullText/87641

Wood JP. Safety of epinephrine for anaphylaxis in the emergency setting. World J Emerg Med 2013;4:245. Available at: www.wjem.com.cn/default/articlef/index/id/257

Peachell P. Regulation of mast cells by β-agonists. Clin Rev Allergy Immunol 2006;31:131-42. Available at: http://link.springer.com/10.1385/CRIAI:31:2:131

Sicherer SH. Prescribing epinephrine for anaphylaxis self-treatment. In: Kelso JM, Feldweg A, editors. UpToDate. Waltham, MA: UpToDate; 2020.

Gosens R, Gross N. The mode of action of anticholinergics in asthma. Eur Respir J 2018;52:1701247. Available at: http://dx.doi.org/10.1183/13993003.01247-2017

Marotta SE, Belchikov Y, Banker K, Marshall PS. Emergency management of acute severe asthma exacerbation in the adult population. J Asthma Allergy Educ 2010;1:174-9. Available at: http://journals.sagepub.com/doi/10.1177/2150129710374232

Williams DM. Clinical pharmacology of corticosteroids. Respir Care 2018;63:655-70. Available at: http://rc.rcjournal.com/lookup/doi/10.4187/respcare.06314

Alqurashi W, Ellis AK. Do corticosteroids prevent biphasic anaphylaxis? J Allergy Clin Immunol Pract 2017;5:1194-205. Available at: https://linkinghub.elsevier.com/retrieve/pii/S2213219817303859

Sheikh A, ten Broek V, Brown SGA, Simons FER. H1-antihistamines for the treatment of anaphylaxis. Allergy 2007;62:830-7. Available at: http://doi.wiley.com/10.1111/j.1398-9995.2007.01435.x

Kawano T, Scheuermeyer FX, Gibo K, et al. H1-antihistamines reduce progression to anaphylaxis among emergency department patients with allergic reactions. Zehtabchi S, editor. Acad Emerg Med 2017;24:733-41. Available at: http://doi.wiley.com/10.1111/acem.13147

Hernández-Cascales J. Does glucagon have a positive inotropic effect in the human heart? Cardiovasc Diabetol 2018;17:148. Available at: https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0791-z

Insuela DBR, Azevedo CT, Coutinho DS, et al. Glucagon reduces airway hyperreactivity, inflammation, and remodeling induced by ovalbumin. Sci Rep 2019;9:6478. Available at: www.nature.com/articles/s41598-019-42981-6

Soong JTY, Soni N. Circulatory shock. Medicine (Baltimore) 2013;41:64-9. Available at: https://linkinghub.elsevier.com/retrieve/pii/S1357303912002812

Hale AJ, Ricotta DN, Herzig SJ, William JH, Freed JA. A quantitative approach to dilutional anemia. J Hematol 2019;8:86-7. Available at: www.thejh.org/index.php/JH/article/view/498